HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Analyzing Lead Levels In Multivitamins, Concerned About NDIs

This article was originally published in The Tan Sheet

Executive Summary

FDA recently tested more than 300 multivitamins for lead and will publish the results in response to pressure from Capitol Hill to follow up on a 2007 report that at least one multivitamin marketed in the U.S. contained "dangerous levels" of lead

You may also be interested in...



NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

FDA tentatively aims this year to complete its guidance for new dietary ingredient notifications, which industry research shows are largely failing to pass the agency's scrutiny

Call For Testing Metal Levels In Supplements Gets Mixed Reviews

Industry stakeholders differ on whether researchers are justified in recommending setting daily limits for toxic metals in dietary supplements

FDA Survey Shows Lead Labeling Not Needed For Supplements – Stakeholders

FDA's survey of lead contamination in hundreds of women's and children's vitamin supplements found what many industry stakeholders expected - lead levels in vitamins are not a cause for concern

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel